Back

Improving the carbon footprint of medications for cardiovascular disease prevention using fixed dose combinations

30 August 2026 (17:10 - 17:20)
Organised by: Logo
Congress Presentation Part of: Environment and heart disease Environmental Aspects of Heart Disease ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Cormac Kennedy

Trinity College Dublin, Dublin (Ireland)

4 More presentations in this session

Presentation thumbnail
Associations of residential outdoor air pollution with incident cardiovascular disease: a nationwide cohort study of 1.8 million adults in Wales.
Mr J. Brown (London, GB)
Abstract Slides
Presentation thumbnail
Micro and Nano-Plastics in coronary blood and air pollution exposure across the spectrum of coronary artery disease
Doctor M. Belmonte (Rome, IT)
Abstract Slides
Presentation thumbnail
Mortality patterns in the context of climate change: a 14-year nationwide analysis of extreme weather events
Doctor A. Kurasz (Bialystok, PL)
Abstract Slides
Presentation thumbnail
Quadrupling of heat-attributable cardiovascular deaths by 2050 across 471 cities in south and southeast Asia: urban greening could prevent 32,000 deaths
Doctor G. Parameswaran (Cleveland, US)
Abstract Slides

Access the full session

Session thumbnail
Environment and heart disease
Video

The Event

Event poster

ESC Congress 2026

30 August 2026 17:10 CET
You may be interested in
thumbnail
Congress Presentation
Polypill to improve adherence in cardiovascular secondary prevention: a real challenge in real practice
3 September 2019
thumbnail
Congress Presentation
Environmental impact analysis of ajmaline challenge protocols: a comparative assessment of carbon footprint reduction in Brugada Syndrome diagnosis
2 September 2024
thumbnail
Congress Presentation
What would be the impact on the burden of hypertension of achieving public health goals?
1 September 2025
thumbnail
Congress Presentation
Monetary costs and LDL-C reduction from upfront combination lipid-lowering therapy with ezetimibe in an irish ACS cohort
4 April 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources